Cerebrospinal fluid biomarkers of Alzheimer's disease

被引：58

作者：

Fagan, Anne M. ^{[1
]}

Holtzman, David M.

机构：

[1] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA

来源：

BIOMARKERS IN MEDICINE | 2010年 / 4卷 / 01期

基金：

美国国家卫生研究院;

关键词：

Alzheimer's disease; amyloid-beta; biomarkers; cerebrospinal fluid; preclinical Alzheimer's disease; tau; MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA-PEPTIDES; PITTSBURGH COMPOUND-B; TRAUMATIC BRAIN-INJURY; CSF BIOMARKERS; A-BETA-42/A-BETA-40; RATIO; ENTORHINAL CORTEX; LONGITUDINAL CSF; TAU-PROTEINS; DIAGNOSIS;

D O I：

10.2217/BMM.09.83

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Alzheimer's disease will reach epidemic proportions within the next 20-30 years if left unchecked. Currently, there are no treatments that prevent or slow Alzheimer's disease but many are being developed. Parallel efforts to develop biomarkers to aid in disease diagnosis and prognosis, and assess disease risk are currently underway. Clinicopathological and biomarker studies have demonstrated that Alzheimer's disease pathology can be detected preclinically. Using biomarkers to identify affected individuals prior to the onset of clinical symptoms and associated synaptic/neuronal loss should enable novel clinical trial design and early mechanism-based therapeutic intervention. This article summarizes the most promising cerebrospinal fluid biomarkers, highlights novel applications and current challenges, and provides a prediction on how the field may evolve in 5-10 years.

引用

页码：51 / 63

页数：13

共 83 条

[51] Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau [J].

Lewczuk, P ;

Esselmann, H ;

Otto, M ;

Maler, JM ;

Henkel, AW ;

Henkel, MK ;

Eikenberg, O ;

Antz, C ;

Krause, WR ;

Reulbach, U ;

Kornhuber, J ;

Wiltfang, J .

NEUROBIOLOGY OF AGING, 2004, 25 (03) :273-281

[52] Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid β peptides [J].

Lewczuk, P ;

Beck, G ;

Esselmann, H ;

Bruckmoser, R ;

Zimmermann, R ;

Fiszer, M ;

Bibl, M ;

Maler, JM ;

Kornhuber, J ;

Wiltfang, J .

CLINICAL CHEMISTRY, 2006, 52 (02) :332-334

[53] Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI:: A multicenter study [J].

Lewczuk, Piotr ;

Kornhuber, Johannes ;

Vanderstichele, Hugo ;

Vanmechelen, Eugeen ;

Esselmann, Hermann ;

Bibl, Mirko ;

Wolf, Stefanie ;

Otto, Markus ;

Reulbach, Udo ;

Koelsch, Heike ;

Jessen, Frank ;

Schroeder, Johannes ;

Schoenknecht, Peter ;

Hampel, Harald ;

Peters, Oliver ;

Weimer, Erik ;

Perneczky, Robert ;

Jahn, Holger ;

Luckhaus, Christian ;

Lamla, Ulrich ;

Supprian, Tillmann ;

Maler, Juan Manuel ;

Wiltfang, Jens .

NEUROBIOLOGY OF AGING, 2008, 29 (06) :812-818

[54] CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment -: A follow-up study [J].

Li, G. ;

Sokal, I. ;

Quinn, J. F. ;

Leverenz, J. B. ;

Brodey, M. ;

Schellenberg, G. D. ;

Kaye, J. A. ;

Raskind, M. A. ;

Zhang, J. ;

Peskind, E. R. ;

Montine, T. J. .

NEUROLOGY, 2007, 69 (07) :631-639

[55] Neuropathologic substrate of mild cognitive impairment [J].

Markesbery, WR ;

Schmitt, FA ;

Kryscio, RJ ;

Davis, DG ;

Smith, CD ;

Wekstein, DR .

ARCHIVES OF NEUROLOGY, 2006, 63 (01) :38-46

[56] CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment [J].

Mattsson, Niklas ;

Zetterberg, Henrik ;

Hansson, Oskar ;

Andreasen, Niels ;

Parnetti, Lucilla ;

Jonsson, Michael ;

Herukka, Sanna-Kaisa ;

van der Flier, Wiesje M. ;

Blankenstein, Marinus A. ;

Ewers, Michael ;

Rich, Kenneth ;

Kaiser, Elmar ;

Verbeek, Marcel ;

Tsolaki, Magda ;

Mulugeta, Ezra ;

Rosen, Erik ;

Aarsland, Dag ;

Visser, Pieter Jelle ;

Schroeder, Johannes ;

Marcusson, Jan ;

de Leon, Mony ;

Hampel, Harald ;

Scheltens, Philip ;

Pirttilae, Tuula ;

Wallin, Anders ;

Jonhagen, Maria Eriksdotter ;

Minthon, Lennart ;

Winblad, Bengt ;

Blennow, Kaj .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04) :385-393

[57] Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease [J].

Mehta, PD ;

Pirttilä, T ;

Mehta, SP ;

Sersen, EA ;

Aisen, PS ;

Wisniewski, HM .

ARCHIVES OF NEUROLOGY, 2000, 57 (01) :100-105

[58] THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].

MIRRA, SS ;

HEYMAN, A ;

MCKEEL, D ;

SUMI, SM ;

CRAIN, BJ ;

BROWNLEE, LM ;

VOGEL, FS ;

HUGHES, JP ;

VANBELLE, G ;

BERG, L .

NEUROLOGY, 1991, 41 (04) :479-486

[59] Mild cognitive impairment represents early-stage Alzheimer disease [J].

Morris, JC ;

Storandt, M ;

Miller, JP ;

McKeel, DW ;

Price, JL ;

Rubin, EH ;

Berg, L .

ARCHIVES OF NEUROLOGY, 2001, 58 (03) :397-405

[60] THE CLINICAL DEMENTIA RATING (CDR) - CURRENT VERSION AND SCORING RULES [J].

MORRIS, JC .

NEUROLOGY, 1993, 43 (11) :2412-2414

← 1 2 3 4 5 6 7 8 9 →